share_log

石藥集團:截至二零二四年一月三十一日止月份之股份發行人的證券變動月報表

CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024

香港交易所 ·  Feb 1 04:38
Summary by Moomoo AI
石藥集團有限公司於2024年1月31日提交了最新的證券變動月報表。報告顯示,根據2015年購股權計劃,公司於本月底的普通股股份期權結存數量為50,000,000股,與上月底結存數量持平,並無新增股份。該股份期權計劃於2015年12月9日生效,並獲股東大會通過。本月內沒有行使任何股份期權,因此沒有因行使期權而得到的資金。石藥集團的普通股股份變動總額為零,顯示公司本月的股份結構保持穩定。報告由董事翟健文於2024年2月1日呈交。
石藥集團有限公司於2024年1月31日提交了最新的證券變動月報表。報告顯示,根據2015年購股權計劃,公司於本月底的普通股股份期權結存數量為50,000,000股,與上月底結存數量持平,並無新增股份。該股份期權計劃於2015年12月9日生效,並獲股東大會通過。本月內沒有行使任何股份期權,因此沒有因行使期權而得到的資金。石藥集團的普通股股份變動總額為零,顯示公司本月的股份結構保持穩定。報告由董事翟健文於2024年2月1日呈交。
Petrochemical Group Limited filed its latest Securities Monthly Change Report on January 31, 2024. The report shows that under the 2015 Share Option Plan, the Company's outstanding number of ordinary share options at the end of the month was 50,000,000 shares, on par with the amount deposited at the end of the previous month, with no new shares added. The share option plan became effective on 9 December 2015 and was approved by the General Meeting. No stock options were exercised during the month, so no funds were received as a result of the exercise of the option. The total change in the common shares of Petrochemical Group was zero, indicating that the company's share structure remained stable this month. The report was submitted by Director Zhai Jianwen on 1 February 2024.
Petrochemical Group Limited filed its latest Securities Monthly Change Report on January 31, 2024. The report shows that under the 2015 Share Option Plan, the Company's outstanding number of ordinary share options at the end of the month was 50,000,000 shares, on par with the amount deposited at the end of the previous month, with no new shares added. The share option plan became effective on 9 December 2015 and was approved by the General Meeting. No stock options were exercised during the month, so no funds were received as a result of the exercise of the option. The total change in the common shares of Petrochemical Group was zero, indicating that the company's share structure remained stable this month. The report was submitted by Director Zhai Jianwen on 1 February 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more